Schousboe A
Adv Exp Med Biol. 1979;123:219-37. doi: 10.1007/978-1-4899-5199-1_13.
Employing primary cultures of astrocytes which seem to constitute a valid model of their in vivo counterparts, it has been demonstrated that this cell type is likely to be of importance in terminating the transmitter activity of GABA. It has been shown that the transport carrier in astrocytes is stereospecific for the C-4 hydrogens of the GABA molecule and that its structural requirements are distinct from those exhibited by the neuronal GABA carrier. beta-Proline was a selective inhibitor of GABA transport in astrocytes, whereas R-trans-4-methyl-4-aminocrotonic acid and S-nipecotic acid seemed to be selective inhibitors of neuronal GABA transport, as studied using very thin slices ("prisms") of brain cortex. These findings may be important for studies on the relative significance of the two transport systems in GABA-mediated neurotransmission, and thus for future pharmacological manipulations of the GABA system. This may eventually be beneficial for the treatment of neurological disorders such as epilepsy, Huntington's chorea and Parkinson's disease in which the GABA system seems to be disturbed (34,60,62).
利用星形胶质细胞的原代培养物(其似乎构成了体内对应物的有效模型),已经证明这种细胞类型在终止GABA的递质活性方面可能很重要。已经表明,星形胶质细胞中的转运载体对GABA分子的C-4氢具有立体特异性,并且其结构要求与神经元GABA载体所表现出的不同。β-脯氨酸是星形胶质细胞中GABA转运的选择性抑制剂,而R-反式-4-甲基-4-氨基巴豆酸和S-哌啶酸似乎是神经元GABA转运的选择性抑制剂,这是使用大脑皮层的非常薄的切片(“棱柱体”)进行研究所发现的。这些发现对于研究这两种转运系统在GABA介导的神经传递中的相对重要性可能很重要,因此对于未来对GABA系统的药理学操纵也很重要。这最终可能有益于治疗诸如癫痫、亨廷顿舞蹈病和帕金森病等神经系统疾病,其中GABA系统似乎受到干扰(34,60,62)。